EUROCELL PLC |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 137 GBX | +2.24% |
|
+2.62% | +4.58% |
| Mar. 27 | Prudential Chair Shriti Vadera buys 50,000 shares | AN |
| Mar. 22 | Transcript : Eurocell plc, 2023 Earnings Call, Mar 22, 2024 |
Summary
- Overall, and from a short-term perspective, the company presents an interesting fundamental situation.
Strengths
- The company's earnings per share (EPS) are expected to grow significantly over the next few years according to the consensus of analysts covering the stock.
- The stock, which is currently worth 2024 to 0.58 times its sales, is clearly overvalued in comparison with peers.
- The company is one of the best yield companies with high dividend expectations.
- For the last few months, EPS revisions have remained quite promising. Analysts now anticipate higher profitability levels than before.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
- The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.
Weaknesses
- With relatively low growth outlooks, the group is not among those with the highest revenue growth potential.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- For the past year, analysts have significantly revised downwards their profit estimates.
- Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Construction Supplies & Fixtures
| 1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
|---|---|---|---|---|
| +4.58% | 181M | C | ||
| +55.07% | 2.88B | B+ | ||
| +0.37% | 1.57B | C+ | ||
| +3.79% | 1.11B | - | - | |
| +15.98% | 755M | - | - | |
| -11.11% | 638M | - | ||
| +50.62% | 511M | - | - | |
| -20.84% | 458M | - | ||
| -4.69% | 331M | - | ||
| -29.73% | 277M | - | - |
Investor Rating
Trading Rating
ESG Refinitiv
Financials
Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances
Valuation
P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
Yield
Momentum
1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision
Consensus
Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion
Business Predictability
Analyst Coverage
Divergence of Estimates
-
Divergence of analysts' opinions
-
Divergence of Target Price
Earnings quality
Environment
Emissions
Innovation
Use of resources
Governance
CSR Strategy
Management
Shareholders
Controversy
Controversy
Technical analysis
ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
- Stock Market
- Equities
- ECEL Stock
- Ratings Eurocell plc
